Homepage

Mangoceuticals, Inc.

MGRX NASDAQ Categories PDF
Healthcare · Medical - Healthcare Information Services · United States · Updated May 11, 11:00am
$0.45
Price
$4.5M
Market Cap
3
Employees
2.12
Beta
Jacob D. Cohen
CEO
Business Description

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Business History
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-0.22
Stock Price: $0.45
EPS (Diluted): -2.05
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
0.49
Stock Price: $0.45
Total Equity: $15.20M
Shares: 10,071,609
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-0.33
Market Cap: $4.51M
Total Debt: $307,823
Cash: $1.49M
EBITDA: -$18.82M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$6.3M
Market Cap: $4.51M
Total Debt: $307,823
Cash: $1.49M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
54.9%
Gross Profit: $250,386
Revenue: $456,021
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-4,200.5%
Operating Income: -$19.15M
Revenue: $456,021
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-4,526.9%
Net Income: -$20.64M
Revenue: $456,021
ROE (Profit from shareholder equity)
CALC
Net Income / Total Equity
-135.8%
Net Income: -$20.64M
Total Equity: $15.20M
ROIC (Profit from all invested capital)
CALC
NOPAT / Invested Capital
-136.6%
Operating Income: -$19.15M
Tax Rate: 0.0%
Equity: $15.20M
Total Debt: $307,823
Cash: $1.49M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
1.74
Current Assets: $1.55M
Current Liabilities: $890,568
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.02
Short-Term Debt: $307,823
Long-Term Debt: $0.00
Total Debt: $307,823
Total Equity: $15.20M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$0.05
Revenue: $456,021
Shares: 10,071,609
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$1.51
Total Equity: $15.20M
Shares: 10,071,609
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-0.58
Operating CF: -$5.85M
CapEx: -$5.00
Shares: 10,071,609
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.45
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$20.64M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares MGRX against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $0 $8,939 $731,493 $615,873 $456,021
Cost of Revenue $0 $4,089 $299,992 $235,909 $205,635
Gross Profit $0 $4,850 $431,501 $379,964 $250,386
Operating Expenses $17,520 $2.0M $9.7M $8.4M $19.4M
Operating Income $-17,520 -$2.0M -$9.2M -$8.0M -$19.2M
Net Income $-17,701 -$2.0M -$9.2M -$8.7M -$20.6M
EBITDA $-17,520 -$2.0M -$8.1M -$8.0M -$18.8M
EPS $-0.02 $-1.73 $-8.58 $-4.40 $-2.05
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $22,550 $682,860 $739,006 $58,653 $1.5M
Total Current Assets $22,550 $694,605 $818,460 $75,595 $1.5M
Total Assets $22,550 $1.0M $1.1M $15.4M $16.1M
Current Liabilities $39,270 $260,577 $211,078 $1.4M $890,568
Long-Term Debt $0 $0 $0 $0 $0
Total Liabilities $39,270 $389,257 $276,039 $1.4M $890,568
Total Equity $-16,720 $614,030 $774,754 $13.9M $15.2M
Retained Earnings $-17,701 -$2.0M -$11.2M -$20.8M -$40.6M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-17,520 -$1.3M -$7.0M -$4.9M -$5.9M
Capital Expenditure $0 $-43,102 $-3,519 $0 $-5
Free Cash Flow $-17,520 -$1.4M -$7.0M -$4.9M -$5.9M
Acquisitions (net) $0 $0 $0 $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash $22,550 $660,310 $56,146 $-680,353 $1.4M
Analyst Estimates (Annual)
Metric 2023
Revenue $17,878
$17,878 – $17,878
EBITDA $0
Net Income $0
EPS —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth — +8,083.2% -15.8% -26.0%
Gross Profit Growth — +8,796.9% -11.9% -34.1%
Operating Income Growth -11,267.5% -362.9% +13.5% -140.3%
Net Income Growth -11,187.8% -361.1% +5.5% -137.1%
EBITDA Growth -11,245.4% -307.2% +1.6% -136.3%
Community AI Feedback
Sign in to Contribute
No community reviews yet for MGRX. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27